MG
ELAN icon

Michael Gelband’s Elanco Animal Health ELAN Stock Holding History

Michael Gelband’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Sell
446,179
-123,853
-22% -$2.86M 0.07% 269
2026
Q1 		$13.6M Sell
570,032
-193,299
-25% -$4.73M 0.11% 166
2025
Q4 		$17.3M Buy
763,331
+491,617
+181% +$10.7M 0.14% 125
2025
Q3 		$5.47M Buy
+271,714
New +$4.55M 0.06% 375
2025
Q1 		– Sell
-191,283
Closed -$2.32M – 1602
2024
Q4 		$2.32M Sell
191,283
-843,055
-82% -$11M 0.02% 673
2024
Q3 		$15.2M Buy
1,034,338
+1,000,068
+2,918% +$13.9M 0.09% 170
2024
Q2 		$495K Buy
+34,270
New +$548K ﹤0.01% 1211
2024
Q1 		– Sell
-165,105
Closed -$2.46M – 1611
2023
Q4 		$2.46M Sell
165,105
-46,280
-22% -$524K 0.02% 520
2023
Q3 		$2.38M Buy
211,385
+181,011
+596% +$2.1M 0.02% 625
2023
Q2 		$306K Sell
30,374
-715,371
-96% -$6.64M ﹤0.01% 1534
2023
Q1 		$7.01M Buy
+745,745
New +$8.8M 0.06% 399
2022
Q4 		– Sell
-168,767
Closed -$2.09M – 1750
2022
Q3 		$2.09M Sell
168,767
-228,889
-58% -$4M 0.03% 784
2022
Q2 		$7.81M Buy
+397,656
New +$9.41M 0.1% 254
2022
Q1 		– Sell
-196,490
Closed -$5.58M – 2307
2021
Q4 		$5.58M Buy
196,490
+92,773
+89% +$2.89M 0.06% 399
2021
Q3 		$3.31M Buy
103,717
+29,850
+40% +$1M 0.04% 540
2021
Q2 		$2.56M Buy
73,867
+13,621
+23% +$449K 0.03% 571
2021
Q1 		$1.77M Buy
+60,246
New +$1.85M 0.03% 615
2020
Q4 		– Sell
-31,378
Closed -$876K – 2056
2020
Q3 		$876K Sell
31,378
-74,002
-70% -$1.88M 0.02% 741
2020
Q2 		$2.26M Buy
+105,380
New +$2.33M 0.06% 379
2019
Q4 		– Sell
-88,403
Closed -$2.35M – 1621
2019
Q3 		$2.35M Buy
+88,403
New +$2.65M 0.08% 211
2019
Q2 		– Sell
-92,124
Closed -$2.95M – 1160
2019
Q1 		$2.95M Sell
92,124
-103,006
-53% -$3.17M 0.22% 80
2018
Q4 		$6.15M Buy
+195,130
New +$6.39M 0.43% 34

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Michael Gelband's ELAN Position: Q2 2026 in Review

Michael Gelband reduced its Elanco Animal Health (ELAN) stake by 22% in Q2 2026, selling an estimated $2.86M and leaving 446,179 shares worth $11M. The position accounts for 0.07% of the portfolio, ranked #269.

Michael Gelband first reported a position in ELAN in Q4 2018 and has held it in 22 quarters since. The position peaked at $17.3M in Q4 2025. 517 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Michael Gelband held 446,179 shares of Elanco Animal Health worth $11M as of Q2 2026.
  • Michael Gelband sold 123,853 Elanco Animal Health shares in Q2 2026, an estimated $2.86M.
  • Elanco Animal Health made up 0.07% of Michael Gelband's portfolio in Q2 2026, its #269 holding.
  • Michael Gelband first reported a position in Elanco Animal Health in Q4 2018 and has held it in 22 quarters since.
  • Michael Gelband's Elanco Animal Health position peaked at $17.3M in Q4 2025.
  • 517 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.